BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 30467121)

  • 1. LRRK2 and Rab GTPases.
    Pfeffer SR
    Biochem Soc Trans; 2018 Dec; 46(6):1707-1712. PubMed ID: 30467121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
    Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
    Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 phosphorylation of Rab GTPases in Parkinson's disease.
    Pfeffer SR
    FEBS Lett; 2023 Mar; 597(6):811-818. PubMed ID: 36114007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the cellular consequences of LRRK2-mediated Rab protein phosphorylation.
    Fasiczka R; Naaldijk Y; Brahmia B; Hilfiker S
    Biochem Soc Trans; 2023 Apr; 51(2):587-595. PubMed ID: 36929701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes.
    Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Romo Lozano M; Rivero-Ríos P; Hilfiker S
    Biochem Soc Trans; 2017 Feb; 45(1):147-154. PubMed ID: 28202668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
    Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of LRRK2 in Intracellular Organelle Dynamics.
    Boecker CA
    J Mol Biol; 2023 Jun; 435(12):167998. PubMed ID: 36764357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of phospho-specific Rab protein antibodies to monitor
    Lis P; Burel S; Steger M; Mann M; Brown F; Diez F; Tonelli F; Holton JL; Ho PW; Ho SL; Chou MY; Polinski NK; Martinez TN; Davies P; Alessi DR
    Biochem J; 2018 Jan; 475(1):1-22. PubMed ID: 29127256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of Rab GTPases in the regulation of membrane trafficking.
    Waschbüsch D; Khan AR
    Traffic; 2020 Nov; 21(11):712-719. PubMed ID: 32969543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites.
    Nirujogi RS; Tonelli F; Taylor M; Lis P; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2021 Jan; 478(2):299-326. PubMed ID: 33367571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson's disease-linked LRRK2 kinase.
    Dhekne HS; Tonelli F; Yeshaw WM; Chiang CY; Limouse C; Jaimon E; Purlyte E; Alessi DR; Pfeffer SR
    Elife; 2023 Oct; 12():. PubMed ID: 37874635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A.
    Rivero-Ríos P; Romo-Lozano M; Madero-Pérez J; Thomas AP; Biosa A; Greggio E; Hilfiker S
    J Biol Chem; 2019 Mar; 294(13):4738-4758. PubMed ID: 30709905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease.
    Cookson MR
    Biochem Soc Trans; 2016 Dec; 44(6):1603-1610. PubMed ID: 27913668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases.
    Steger M; Tonelli F; Ito G; Davies P; Trost M; Vetter M; Wachter S; Lorentzen E; Duddy G; Wilson S; Baptista MA; Fiske BK; Fell MJ; Morrow JA; Reith AD; Alessi DR; Mann M
    Elife; 2016 Jan; 5():. PubMed ID: 26824392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRRK2 binds to the Rab32 subfamily in a GTP-dependent manner
    McGrath E; Waschbüsch D; Baker BM; Khan AR
    Small GTPases; 2021 Mar; 12(2):133-146. PubMed ID: 31552791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Update on the Interplay between LRRK2, Rab GTPases and Parkinson's Disease.
    Komori T; Kuwahara T
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of PPM1H phosphatase tunes Parkinson's disease-linked LRRK2 kinase-mediated Rab GTPase phosphorylation and ciliogenesis.
    Yeshaw WM; Adhikari A; Chiang CY; Dhekne HS; Wawro PS; Pfeffer SR
    Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2315171120. PubMed ID: 37889931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins.
    Berndsen K; Lis P; Yeshaw WM; Wawro PS; Nirujogi RS; Wightman M; Macartney T; Dorward M; Knebel A; Tonelli F; Pfeffer SR; Alessi DR
    Elife; 2019 Oct; 8():. PubMed ID: 31663853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis.
    Steger M; Diez F; Dhekne HS; Lis P; Nirujogi RS; Karayel O; Tonelli F; Martinez TN; Lorentzen E; Pfeffer SR; Alessi DR; Mann M
    Elife; 2017 Nov; 6():. PubMed ID: 29125462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the effects of GTPase and kinase domain mutations on LRRK2 endosomal localization and activity.
    Rinaldi C; Waters CS; Li Z; Kumbier K; Rao L; Nichols RJ; Jacobson MP; Wu LF; Altschuler SJ
    Cell Rep; 2023 May; 42(5):112447. PubMed ID: 37141099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.